Spectrofluorimetric Determination of Nepafenac Through Quenching Lanthanide Luminescence in Drug Substance and in Ophthalmic Suspension
Rizk, M., Attia, A., Hussien, E., Aboul-Alamain, F., Elshahed, M. (2020). Spectrofluorimetric Determination of Nepafenac Through Quenching Lanthanide Luminescence in Drug Substance and in Ophthalmic Suspension. EKB Journal Management System, 4(4), 161-168. doi: 10.21608/aprh.2020.32097.1111
Mohamed Rizk; Ali Attia; Emad Hussien; Fatma Aboul-Alamain; Mona Elshahed. "Spectrofluorimetric Determination of Nepafenac Through Quenching Lanthanide Luminescence in Drug Substance and in Ophthalmic Suspension". EKB Journal Management System, 4, 4, 2020, 161-168. doi: 10.21608/aprh.2020.32097.1111
Rizk, M., Attia, A., Hussien, E., Aboul-Alamain, F., Elshahed, M. (2020). 'Spectrofluorimetric Determination of Nepafenac Through Quenching Lanthanide Luminescence in Drug Substance and in Ophthalmic Suspension', EKB Journal Management System, 4(4), pp. 161-168. doi: 10.21608/aprh.2020.32097.1111
Rizk, M., Attia, A., Hussien, E., Aboul-Alamain, F., Elshahed, M. Spectrofluorimetric Determination of Nepafenac Through Quenching Lanthanide Luminescence in Drug Substance and in Ophthalmic Suspension. EKB Journal Management System, 2020; 4(4): 161-168. doi: 10.21608/aprh.2020.32097.1111

Spectrofluorimetric Determination of Nepafenac Through Quenching Lanthanide Luminescence in Drug Substance and in Ophthalmic Suspension

Journal of Advanced Pharmacy Research
Article 4, Volume 4, Issue 4, October 2020, Page 161-168  XML PDF (512.97 K)
Document Type: Research Article
DOI: 10.21608/aprh.2020.32097.1111
View on SCiNiTO View on SCiNiTO
Authors
Mohamed Rizk1; Ali Attia2; Emad Hussien2; Fatma Aboul-Alamain3; Mona Elshahed email 1
1Department of Analytical Chemistry, Faculty of Pharmacy, University of Helwan, Cairo, Egypt.
2National Organization for Drug Control and Research, Cairo, Egypt.
3VACSERA Holding Company for Biological Products and Vaccines, Giza, Egypt.
Abstract
Objective: A simple, selective and sensitive spectrofluorometric method is established for the quantitative assay of Nepafenac (NEPA) in pure form and in ophthalmic suspension dosage form. Methods: The fluorescence quenching of Terbium-Tris complex is measured at λ em580 nm after using λ ex 237 nm. The effect of pH, volume of terbium solution and reaction time on fluorescence quenching were studied. The complex formation was found to be highly dependent on the pH. The optimum fluorescence quenching was achieved by using 1.0 ml of (2 × 10-3M) Tb3+ solution and 1.0 ml of Tris buffer solution (pH 10.0). Results: The formed complex was stable for 15 minutes from the starting time of the reaction at room temperature.  The fluorescence quenching of Terbium-Tris complex was linear within the concentration range of 0.25 -10 μg ml-1 with mean percentage recovery of 99.85 ± 0.77 and Correlation Coefficient of 0.9996 (n=5). The sensitivity of the method could be evaluated by limit of detection (LOD) (0.008 µg ml-1) and limit of quantitation (LOQ) (0.024 µg ml-1). Conclusion: Statistical comparison of the results with those of a reported method revealed good agreement.
Keywords
Nepafenac; Terbium; Spectrofluorimetric determination
Statistics
Article View: 350
PDF Download: 539